H. Jeffrey Wilkins is Chief Medical Officer at Avalo Therapeutics, Inc. (AVTX). They have made 2 open-market trades across 2 companies since 2021, most recently 2021-12-10.
CIK 0001779160
2 open-market purchases totalling $12K since 2021, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.